Evaluating stress urinary incontinence in postmenopausal women with osteoporosis
Stress Urinary Incontinence and Sarcopenia in Postmenopausal Osteoporosis: The Intersection of Muscle Loss and Pelvic Dysfunction
This study looks at how common stress urinary incontinence is in postmenopausal women with and without osteoporosis, and how it affects their quality of life.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 50 Years to 75 Years |
| Sex | Female |
| Sponsor | Beylikduzu State Hospital Academic / other |
| Locations | 1 site (Istanbul) |
| Trial ID | NCT06655701 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the prevalence of stress urinary incontinence among postmenopausal women, both with and without osteoporosis, and to evaluate its impact on their quality of life. The study will involve 100 women aged 50-75 who have undergone recent Dual-X-ray Absorptiometry (DXA) measurements. Participants will provide sociodemographic data and complete questionnaires to determine the presence of urinary incontinence and its effects on their quality of life. Additionally, the study will evaluate sarcopenia using established criteria, including assessments of muscle mass and strength.
Who should consider this trial
Good fit: Ideal candidates are postmenopausal women aged 50-75 with recent DXA measurements indicating either osteoporosis or non-osteoporotic status.
Not a fit: Patients with neurological diseases, psychiatric disorders, or those on medications affecting study outcomes may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of the relationship between osteoporosis, sarcopenia, and urinary incontinence, leading to improved management strategies for affected patients.
How similar studies have performed: While the specific combination of osteoporosis, sarcopenia, and urinary incontinence has not been extensively studied, related research has shown significant associations between these conditions.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Postmenopausal women with DXA measurements performed within the last 6 months. * Based on DXA measurements: Femoral neck and L1-L4 T-scores of -1 and above will be included in the control group (non-osteoporotic). Femoral neck and L1-L4 T-scores of -2.5 and below will be included in the osteoporosis group. * Aged 50-75 years Exclusion Criteria: * Refusal to participate in the study. * History of neurological diseases, infections, surgeries, or trauma that could cause urinary incontinence or muscle loss. * Presence of psychiatric disorders. * Cognitive impairments. * Use of medications that could affect the study results.
Where this trial is running
Istanbul
- Beylikdüzü State Hospital — Istanbul, Turkey (Türkiye) (Recruiting)
Study contacts
- Study coordinator: Büşra Şirin Ahısha, MD
- Email: bsrn080@gmail.com
- Phone: (0212) 856 27 40
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.